AZ-LIMELIGHT-NETWORKS
Limelight Networks, Inc. (Nasdaq:LLNW), a global leader in digital content delivery, today announced music-streaming leader Rhapsody has signed an agreement, extending the companies’ 15-year relationship. Rhapsody will leverage the Limelight Orchestrate Delivery and Storage services to continue to deliver songs to its 3.5 million customers around the world.
Rhapsody, based in Seattle, Washington, was the first paid online music subscription service and has been delivering streaming music to subscribers for 15 years. By using Limelight’s content delivery network, Rhapsody consistently delivers music to its customers in milliseconds across a wide variety of connected devices, resulting in a high quality listening experience. In addition, by utilizing both the Orchestrate Delivery and Storage services, Rhapsody is able to place its vast library of more than 35 million songs closer to the end-user, resulting in improved speed of delivery globally.
“The team at Limelight has genuine interest in helping Rhapsody enhance its service, and is always willing to work with us on innovative solutions,” said Paul Vandegrift, director, business solutions management at Rhapsody. “We’ve had a long and very positive relationship with Limelight. They are easy to work with and always responsive. We look forward to continuing our relationship and working together in the future.”
“We are proud that over the many years, Limelight’s investments in our infrastructure, capabilities and global expansion have continued to support Rhapsody’s growth and the customer experience for millions of their subscribers. We look forward to continuing to work together to ensure their music is flawlessly delivered, resulting in an excellent listening experience for their customers,” said George Vonderhaar, chief sales officer, at Limelight.
More information on the Limelight Orchestrate Delivery platform is available at https://www.limelight.com/delivery .
About Rhapsody
Rhapsody pioneered the paid music streaming
service when it launched in 2001. Rhapsody was the first music service
to sign licensing agreements with all major labels, the first streaming
music service to launch an iOS app, the first streaming service to
provide off-line play, to offer a broad catalog of major label content
for full-track play on Twitter, and the first to give artists a platform
to reach their super-fans with merchandise offers. Today, under the
Rhapsody and Napster brands, they are a top tier streaming music service
with over 3.5 million paying customers, a global catalog of more than 35
million songs available in more than 30 countries. Follow @Rhapsody on
Twitter and keep up with the latest on the Rhapsody Facebook page.
About Limelight
Limelight Networks (NASDAQ: LLNW), a global
leader in digital content delivery, empowers customers to better engage
online audiences by enabling them to securely manage and
globally deliver digital content, on any device. The company’s award
winning Limelight Orchestrate™ platform includes an integrated suite of
content delivery technology and services that helps organizations secure
digital content, deliver exceptional multi-screen experiences, improve
brand awareness, drive revenue, and enhance customer relationships — all
while reducing costs. For more information, please visit www.limelight.com
,
read our blog
,
follow us on Twitter
, Facebook
and LinkedIn
and
be sure to visit Limelight
Connect
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160412005158/en/
Contact:
fama PR, Inc. for Limelight
Ted Weismann, 617-986-5009
limelight@famapr.com
or
Investor
Inquiries
ir@limelight.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom